NCT03098589 2025-03-30Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)CelgeneCompleted1,149 enrolled
NCT01208051 2021-07-15Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid CancerNational Cancer Institute (NCI)Phase 1/2 Completed127 enrolled 18 charts
NCT00287287 2020-06-12REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid CarcinomasUniversity of KentuckyPhase 2 Completed25 enrolled 9 charts